How low is really low? Comparison of two C-peptide assays to establish residual C-peptide production in type 1 diabetes.
Kitty de LeurCharlotte E VollenbrockPim DekkerMartine de VriesErwin BirnieDick MulBruce H R WolffenbuttelJoost GroenHenk-Jan AanstootLianne S M BoestenPublished in: Diabetic medicine : a journal of the British Diabetic Association (2022)
The IRMA provided the lowest threshold for quantification of serum C-peptide. LoQ of commercially available assays should be established in-house before applying them in research studies and clinical trials in which low C-peptide levels have clinical or scientific relevance.